Solace Therapeutics Inc.
Reversible, office-based SUI solution
This article was originally published in Start Up
Executive Summary
Solace Therapeutics Inc.’s Solace Bladder Control System is a small, lightweight, polyurethane balloon device that fills with air once it is placed within the bladder, where it floats unobtrusively at the top of the organ, not blocking the urethra. The device is designed to eliminate or reduce involuntary urinary leakage by acting as a “shock absorber” to reduce the temporary peak pressure changes in the bladder that cause urinary leakage.
You may also be interested in...
Medtech Start-Ups Innovate In Urinary Incontinence
Angel- and venture-backed medtech start-ups are working to fill the tremendous unmet need for alternative device options for treating (not just managing) female urinary incontinence a condition that has a significant impact on quality of life for millions of women. In this issue we profile Floelle, InControl Medical, NexHand, and Solace Therapeutics.
Finance Watch: More Job Cuts As Companies Prioritize Cash Conservation
Public Company Edition: Applied Molecular Transport, Scholar Rock, Agios and others join many of their peers in revising their strategies and downsizing their teams. Also, Zentalis grossed $200m from a follow-on offering and OKYO Pharma went public in the year’s smallest biopharma IPO in the US.
XACT ACE Robotics System Receives Expanded FDA Clearance For Ablation Procedures
Medtech Insight spoke with XACT Robotics’ executive chairman Harel Gadot about plans for the FDA-cleared ACE robotic system and its market opportunities.